Taejoon Pharmaceutical Co., Ltd.
Clinical trials sponsored by Taejoon Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A multi-center, randomized, Double-Blind, Placebo-Controlled, parallel design, phase ⅱ clinical trial to evaluate the safety and efficacy of TJO-087 Results expected Oct 2026 (estimated)
- A daily eye drop might slow childhood nearsightedness. a trial puts it to the test. Results expected Apr 2027 (estimated)